Insider · CIK 0001673528

Faga Daniel

CIK 0001673528 Name as filed on the most recent filing

Filed as Faga Daniel (15)

29 transaction lines · from 15 filings · filed 2017-05-17 to 2026-03-27 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

29 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-03-27 S, Open-market sale Anaptysbio, IncANAB 10 lines 1,089,199, disposed Open Form 4 filing 0001673528-26-000007
2026-01-08 S, Open-market sale Anaptysbio, IncANAB 638,504, disposed Open Form 4 filing 0001673528-26-000006
2026-01-07 S, Open-market sale Anaptysbio, IncANAB 415,102, disposed Open Form 4 filing 0001673528-26-000004
2026-01-05 S, Open-market sale Anaptysbio, IncANAB 662,267, disposed Open Form 4 filing 0001673528-26-000002
2024-03-25 S, Open-market sale Anaptysbio, IncANAB 64,268, disposed Open Form 4 filing 0001415889-24-009164
2024-03-22 S, Open-market sale Anaptysbio, IncANAB 3,325,185, disposed Open Form 4 filing 0001415889-24-009164
2024-01-08 S, Open-market sale Anaptysbio, IncANAB 149,747, disposed Open Form 4 filing 0001209191-24-001277
2021-02-02 S, Open-market sale Mirati Therapeutics, Inc.MRTX 260,469, disposed Open Form 4 filing 0001214659-21-001205
2021-01-07 S, Open-market sale Mirati Therapeutics, Inc.MRTX 2 lines 567,854, disposed Open Form 4 filing 0001214659-21-000333
2017-10-24 S, Open-market sale Spark Therapeutics, Inc.ONCE 127,500, disposed Open Form 4 filing 0001609351-17-000109
2017-10-20 S, Open-market sale Spark Therapeutics, Inc.ONCE 479,700, disposed Open Form 4 filing 0001609351-17-000109
2017-09-19 S, Open-market sale Spark Therapeutics, Inc.ONCE 127,500, disposed Open Form 4 filing 0001609351-17-000106
2017-09-12 S, Open-market sale Spark Therapeutics, Inc.ONCE 2 lines 495,009, disposed Open Form 4 filing 0001609351-17-000104
2017-09-07 S, Open-market sale Spark Therapeutics, Inc.ONCE 2 lines 255,045, disposed Open Form 4 filing 0001609351-17-000102
2017-07-24 S, Open-market sale Spark Therapeutics, Inc.ONCE 210,000, disposed Open Form 4 filing 0001609351-17-000081
2017-06-29 S, Open-market sale Spark Therapeutics, Inc.ONCE 282,195, disposed Open Form 4 filing 0001609351-17-000066
2017-05-15 S, Open-market sale Spark Therapeutics, Inc.ONCE 256,050, disposed Open Form 4 filing 0001609351-17-000037

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 29
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Faga Daniel, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001673528

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.